FDA Drug Application (021654) for LOVAZA by SMITHKLINE BEECHAM

Back to FDA Applications sponsored by SMITHKLINE BEECHAM

Application Number021654
Product Number001
FormCAPSULE;ORAL
Dosage1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOVAZA
Active IngredientOMEGA-3-ACID ETHYL ESTERS



Back to FDA Applications sponsored by SMITHKLINE BEECHAM

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.